ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2539

The Validity and Reliability of Turkish Version of the Jenkins Sleep Scale in Rheumatoid Arthritis

M Tuncay Duruoz1, Cagri Ünal2, Firat Ulutatar3, Canan Sanal Top2 and Osman Hakan Gunduz4, 1Dept of PM&R, Rheumatology Clinic, Marmara University Medical School, Istanbul, Turkey, 2PM&R, Marmara University Medical School, Istanbul, Turkey, 3Physical Medicine and Rehabilitation Department, Marmara University Medical School, Istanbul, Turkey, 4Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Outcome measures, rheumatoid arthritis (RA) and sleep disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Research Methodology Poster (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  The Jenkins Sleep Scale has 4 questions to assess the estimation of sleep problems in clinical research. It was developed in USA (1).  

Aim: To assess the validity and reliability of the Jenkins Sleep Scale (JSS) in a Turkish population with Rheumatoid Arthritis (RA).

Methods:  The Jenkins Sleep Scale was translated from English to Turkish with back translation method.  Patients with RA according to ACR 2010  criteria  were recruited into the study consecutively. The internal consistency (Cronbach’s alpha) was assessed for reliability. Face validity and construct validity (convergent and divergent validities) were evaluated to assess its usefulness in Turkish population.  The relation of the JSS with  the Pittsburgh Sleep Quality Index (PSQI), Multidimensional Assessment of Fatigue (MAF) scale, subgroups of Nottingham Health Profile (NHP) (energy level-EL, pain-P, emotional reactions-ER, sleep-S, social isolation-SI, physical mobility (PM) and Health Assessment Questionnaire (HAQ)  were assessed for convergent validity. The relation of the JSS with age,  disease duration, VAS-patient global and DAS28  were assessed for divergent validity. Spearman’s  correlation coeficient (rho) was used to assessed the relation between quantitative parameters. P<0.05  was accepted as significant.

Results:

Sixtyone RA patients (48 female, 13 male) with  50.52  (SD:10.84) mean of age were recruited into the study. The Cronbach’s alpha of JSS was 0.80.  All questions and the answer choices of the JSS  were well understood by patients which showed the face validity. The JSS has good correlation with functional  parameters (convergent) and it has poor or not significant correlations with non functional parameters (divergent) (Table). It means that JSS has good construct validity. The JSS has the best correlation with the Pittsburgh Sleep Quality Index (rho=0.76). 

Convergent validity of JSS

Spearman’s (rho)

Significance (p)

PSQI

0.76

<0.0001

NHP-EL

0.56

<0.0001

NHP-P

0.57

<0.0001

NHP-ER

0.60

<0.0001

NHP-S

0.45

<0.0001

NHP-SI

0.55

<0.0001

NHP-PM

0.56

<0.0001

HAQ

0.55

<0.0001

MAF

0.47

<0.0001

Divergent validity of JSS

Spearman’s (rho)

Significance (p)

Age

0.21

0.1130

Disease duration

0.22

0.0860

VAS-patientglobal

0.38

0.002

DAS28

– 0.044

0.73

Conclusion: The Jenkins Sleep Scale is valid and reliable instrument in RA patients in a Turkish population. It  is practical and non time consuming scale to use in daily practice and the clinical researches.

1. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41(4):313-21


Disclosure: M. T. Duruoz, None; C. Ünal, None; F. Ulutatar, None; C. Sanal Top, None; O. Hakan Gunduz, None.

To cite this abstract in AMA style:

Duruoz MT, Ünal C, Ulutatar F, Sanal Top C, Hakan Gunduz O. The Validity and Reliability of Turkish Version of the Jenkins Sleep Scale in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-validity-and-reliability-of-turkish-version-of-the-jenkins-sleep-scale-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-validity-and-reliability-of-turkish-version-of-the-jenkins-sleep-scale-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology